Nx4 Reduced Susceptibility to Distraction in an Attention Modulation Task

Kathrin Mayer1, Marina Krylova1,2, Sarah Alizadeh1,2

  • 1Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.

Frontiers in Psychiatry
|December 16, 2021
PubMed
Summary

The stress-relieving medication Neurexan (Nx4) reduced distractibility by emotional stimuli, improving attention. This study used an enhanced Attention Modulation by Salience Task (AMST) with EEG to measure effects on reaction times and brain activity.

Related Concept Videos